No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ELAN240816C16000
- 0.08
- -0.04-33.33%
15min DelayClose Jul 22 16:00 ET
0.08High0.08Low
0.08Open0.12Pre Close5 Volume603 Open Interest16.00Strike Price40.00Turnover58.61%IV25.63%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type0.0879Delta0.0812Gamma170.67Leverage Ratio-0.0063Theta0.0007Rho15.00Eff Leverage0.0053Vega
Intraday
- 5D
- Daily
News
Elanco (ELAN) Stock Declines After Sale of Aqua Business
In 2025, further improvements are projected, with net debt to adjusted EBITDA reaching the high-3x to the low-4x range.
Why Investors Shouldn't Be Surprised By Elanco Animal Health Incorporated's (NYSE:ELAN) 29% Share Price Plunge
Elanco Animal Health Incorporated (NYSE:ELAN) shareholders won't be pleased to see that the share price has had a very rough month, dropping 29% and undoing the prior period's positive performance.
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement
GREENFIELD, Ind., July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on Thursday, August 8, 2024. Elanco will also
Stifel Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Cuts Target Price to $20
Stifel analyst Jonathan Block maintains $Elanco Animal Health(ELAN.US)$ with a buy rating, and adjusts the target price from $22 to $20.According to TipRanks data, the analyst has a success rate of 48
Argus Research Maintains Elanco Animal Health(ELAN.US) With Hold Rating
Argus Research analyst Jasper Hellweg maintains $Elanco Animal Health(ELAN.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 62.7% and a total average return of 9.8
Stifel Nicolaus Sticks to Its Buy Rating for Elanco Animal Health (ELAN)
Comments
$Elanco Animal Health(ELAN.US$ It's time to go back up.
$Elanco Animal Health(ELAN.US$ Barclays and Bank of America both analyst maintained US21 and US22 target price !
$Elanco Animal Health(ELAN.US$ why drop so much ? madness
$Elanco Animal Health(ELAN.US$ buying opprtunity... overreaction. FDA approved new drugs! BUY
1
Jim Cramer highlighted three pet-centric stocks: Chewy, Elanco, and J.M. Smucker, as good picks in a tougher market.
Chewy ( $Chewy(CHWY.US$ ): Cramer praised Chewy's recent rebound and earnings growth, driven by positive trends in pet adoption.
Elanco ( $Elanco Animal Health(ELAN.US$ ): A spin-off from Eli Lilly, Elanco has a promising pipeline, including treatments for canine parvovirus and diabetes in cats.
J.M. Smucker ( $JM Smucker(SJM.US$ ): ...
Chewy ( $Chewy(CHWY.US$ ): Cramer praised Chewy's recent rebound and earnings growth, driven by positive trends in pet adoption.
Elanco ( $Elanco Animal Health(ELAN.US$ ): A spin-off from Eli Lilly, Elanco has a promising pipeline, including treatments for canine parvovirus and diabetes in cats.
J.M. Smucker ( $JM Smucker(SJM.US$ ): ...
From YouTube
5
Read more